Oncology Flashcards
ca125
ovarian cancer
ca19-9
pancreatic cancer
ca15-3
breast cancer
AFP
Hepatocellular cancer, teratoma
CEA
colorectal cancer
s-100
Melanoma, schwannomas
bombesin
Small cell lung carcinoma, gastric cancer, neuroblastoma
raised AFP excludes what
seminomas
features of gardner’s syndrome
- Autosomal dominant familial colorectal polyposis
- Multiple colonic polyps
- Extra colonic diseases include: skull osteoma, thyroid cancer and epidermoid cysts
- Desmoid tumours are seen in 15%
- Mutation of APC gene Chr5
- Patients undergo colectomy to reduce risk of colorectal cancer
- Variant of familial adenomatous polyposis coli
Features of Li-Fraumeni Syndrome
- Autosomal dominant
- Germline mutations to p53 tumour suppressor gene
- High incidence of malignancies particularly sarcomas and leukaemias
Diagnosed when: pt < 45, and first degree relative diagnosed with any cancer below age 45 years and another family member develops malignancy under 45 years or sarcoma at any age
features of BRCA 1 and 2
- Chr 17 (BRCA 1) and Chr 13 (BRCA 2)
- Linked to breast cancer (60%) risk.
- Risk of developing ovarian cancer (55% with BRCA 1 and 25% with BRCA 2).
- BRCA2 mutation is associated with prostate cancer in men
Features of Lynch syndrome (HNPCC)
- Autosomal dominant
- Develop colonic cancer and endometrial cancer at young age
- 80% of affected individuals will get colonic and/ or endometrial cancer
- High risk individuals may be identified using the Amsterdam criteria
What is the amsterdam criteria
- 3 or more family members with a diagnosis of colorectal cancer, one of whom is a first degree (parent, child, sibling) relative of the other two.
- Two successive affected generations.
- One or more colon cancers diagnosed under age 50 years.
- Familial adenomatous polyposis (FAP) has been excluded.
How does a PET scan work
shows glucose uptake (cancer more metabolically active = use more glucose)
use of bleomycin
cytotoxic drug against lymphoma, metastatic germ cell cancer, squamous cell carcinoma and in some regimes non-Hodgkin’s lymphoma
adverse effect of bleomycin
pulmonary fibrosis
use of Cyclophosphamide
against lymphoma
adverse effect of Cyclophosphamide
- haemorrhagic cystitis
- myelosuppression
- transitional cell carcinoma
use of Anthracyclines (e.g. doxorubicin)
against lymphoma
adverse effects of Anthracyclines (e.g. doxorubicin)
cardiomyopathy (heart failure)
use of Docetaxel
against breast and lung cancer
adverse effect of Docetaxel
neutropenia